Stocks TelegraphStocks Telegraph
Stock Ideas

OGEN Financial Statements and Analysis

AMEX : OGEN

Oragenics, Inc.

$0.30
0.0119+4.19%
At Close 4:00 PM
$0.28
-0.02-6.76%
After-Market 05:50 PM
67.98
BESG ScoreESG Rating

OGEN FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

OGEN Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue00007.466K
cost of revenue0906.779K663.414K11.042M4.785K
gross profit0-906.779K-663.414K-11.042M2.681K
gross profit ratio00000.359
research and development expenses879.041K906.779K663.414K768.475K769.35K
general and administrative expenses1.558M1.399M1.797M1.754M1.333M
selling and marketing expenses00000
selling general and administrative expenses1.558M1.399M1.797M1.754M1.333M
other expenses000045.118K
operating expenses2.437M2.306M2.46M2.523M2.094M
cost and expenses2.437M2.306M2.46M2.523M2.094M
interest income9.466K6.405K19.235K38.626K50.613K
interest expense9.971K1.803K7.085K12.231K14.17K
depreciation and amortization-15.614K6.848K6.848K04.785K
ebitda-2.453M-2.299M-2.444M-2.523M-1.994M
ebitda ratio0000-267.068
operating income-2.437M-2.306M-2.46M-2.523M-2.094M
operating income ratio0000-280.531
total other income expenses net-25.59K910.009.27K-10.225M45.118K
income before tax-2.463M-2.305M-2.451M-12.747M-2.013M
income before tax ratio0000-269.607
income tax expense00-6.848K059.288K
net income-2.463M-2.305M-2.451M-12.747M-2.013M
net income ratio0000-269.607
eps-0.38-0.51-0.70-4.14-0.85
eps diluted-0.38-0.51-0.70-4.14-0.85
weighted average shs out6.528M4.529M3.496M3.081M2.356M
weighted average shs out dil6.528M4.529M3.496M3.081M2.356M
Graph

OGEN Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents3.144M1.349M2.072M3.484M5.767M
short term investments00000
cash and short term investments3.144M1.349M2.072M3.484M5.767M
net receivables000035.104K
inventory00000
other current assets969.294K270.334K371.212K382.273K2.012M
total current assets4.113M1.619M2.443M3.866M7.814M
property plant equipment net0009.811K76.736K
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00000
tax assets00000
other non current assets1.091M1.091M1.091M1.091M8.60K
total non current assets1.091M1.091M1.091M1.101M85.336K
other assets00000
total assets5.204M2.71M3.534M4.966M7.899M
account payables1.513M1.18M695.791K1.245M808.935K
short term debt519.392K0126.84K322.514K517.757K
tax payables00000
deferred revenue001.000-808.935K
other current liabilities93.827K202.88K86.054K230.72K884.35K
total current liabilities2.127M1.383M908.686K1.798M1.402M
long term debt00000
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities00000
total non current liabilities00781.846K00
other liabilities00-781.846K00
capital lease obligations000024.337K
total liabilities2.127M1.383M908.686K1.798M1.402M
preferred stock1.593M1.593M1.593M1.593M1.593M
common stock9.388K5.581K4.48K3.081K2.549K
retained earnings-213.437M-210.974M-208.669M-206.218M-193.471M
accumulated other comprehensive income loss00-1.593M-3.081K-1.593M
other total stockholders equity214.913M210.702M209.697M207.791M199.966M
total stockholders equity3.078M1.326M2.625M3.168M6.497M
total equity3.078M1.326M2.625M3.168M6.497M
total liabilities and stockholders equity5.204M2.71M3.534M4.966M7.899M
minority interest00000
total investments00000
total debt519.392K0126.84K322.514K517.757K
net debt-2.625M-1.349M-1.945M-3.161M-5.249M
Graph

OGEN Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax0000-719.776K
stock based compensation58.22K69.344K0402.925K63.628K
change in working capital702.341K-682.76K848.67K124.606K399.027K
accounts receivables0035.104K-21.941K-13.163K
inventory00000
accounts payables601.463K-693.821K598.194K-298.326K-620.379K
other working capital100.878K11.061K215.372K444.873K1.033M
other non cash items-543.243K763.165K10.796M-22.443K719.776K
net cash provided by operating activities-1.545M-3.064M-1.103M-1.503M-2.577M
investments in property plant and equipment-1.000000
acquisitions net001.0063.714K0
purchases of investments00000
sales maturities of investments00000
other investing activites00-1.00M1.000
net cash used for investing activites00-999.999K63.715K0
debt repayment-126.84K-185.863K-180.717K-117.689K-107.89K
common stock issued948.001K1.839M118.00849.808K0
common stock repurchased00000
dividends paid00000
other financing activites821.161K-185.863K00-107.89K
net cash used provided by financing activities821.161K1.653M-180.599K732.119K-107.89K
effect of forex changes on cash00000
net change in cash-723.367K-1.412M-2.283M-707.178K-2.685M
cash at end of period1.349M2.072M3.484M5.767M6.474M
cash at beginning of period2.072M3.484M5.767M6.474M9.158M
operating cashflow-1.545M-3.064M-1.103M-1.503M-2.577M
capital expenditure-1.000000
free cash flow-1.545M-3.064M-1.103M-1.503M-2.577M
Graph

Frequently Asked Questions

How did Oragenics, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, OGEN generated $0.00 in revenue last quarter, while its costs came in at $0.00.

Last quarter, how much Gross Profit did Oragenics, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Oragenics, Inc. reported a $0.00 Gross Profit for the quarter ended Jun 30, 2024.

Have OGEN's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. OGEN incurred $2.44M worth of Operating Expenses, while it generated -$2.44M worth of Operating Income.

How much Net Income has OGEN posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Oragenics, Inc., the company generated -$2.46M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Oragenics, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Oragenics, Inc. as of the end of the last quarter was $3.14M.

What are OGEN's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, OGEN had Total Net Receivables of $0.00.

In terms of Total Assets and Current Assets, where did Oragenics, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of OGEN were $4.11M, while the Total Assets stand at $5.20M.

As of the last quarter, how much Total Debt did Oragenics, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of OGEN's debt was $519.39K at the end of the last quarter.

What were OGEN's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, OGEN reported total liabilities of $2.13M.

How much did OGEN's Working Capital change over the last quarter?

Working Capital Change for OGEN was $702.34K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

OGEN generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. OGEN generated -$1.54M of Cash from Operating Activities during its recently reported quarter.

What was OGEN's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. OGEN reported a -$723.37K Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph